These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30825)

  • 21. Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1290-5. PubMed ID: 8819514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withdrawal of the paradoxal sleep by the clomipramine, electrophysiological, histochemical and biochemical study.
    Passouant P; Cadhilac J; Billiard M
    Int J Neurol; 1975; 10(1-4):186-97. PubMed ID: 171234
    [No Abstract]   [Full Text] [Related]  

  • 23. Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist.
    Tsou K; Patrick SL; Walker JM
    Eur J Pharmacol; 1995 Jul; 280(3):R13-5. PubMed ID: 8566091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in diurnal temperature and feeding patterns of rats during repeated injections of heroin and withdrawal.
    Thronhill JA; Hirst M; Gowdey CW
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):120-31. PubMed ID: 1033735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone-induced or postwithdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant rats.
    Kaymakçalan S; Ayhan IH; Tulunay FC
    Psychopharmacology (Berl); 1977 Dec; 55(3):243-9. PubMed ID: 414285
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of clomipramine and desmethylclomipramine on the in vitro uptake of radiolabelled 5-HT and noradrenaline into rat brain cortical slices.
    Thomas PC; Jones RB
    J Pharm Pharmacol; 1977 Sep; 29(9):562-3. PubMed ID: 21264
    [No Abstract]   [Full Text] [Related]  

  • 27. Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study.
    Acquas E; Pisanu A; Marrocu P; Goldberg SR; Di Chiara G
    Eur J Pharmacol; 2001 May; 419(2-3):155-61. PubMed ID: 11426837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of clomipramine and other inhibitors of monoamine uptake on the sexual behaviour of female rats and rhesus monkeys.
    Everitt BJ
    Postgrad Med J; 1977; 53 Suppl 4():202-10. PubMed ID: 414218
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of clomipramine and its withdrawal on some nocturnal hormone profiles--a preliminary report.
    Lacey JH; Crisp AH; Groom GV; Seldrup J
    Postgrad Med J; 1977; 53 Suppl 4():182-9. PubMed ID: 341106
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of long-term administration of toxic doses of clomipramine on plasma prolactin, luteinizing hormone, follicle stimulating hormone and testosterone in the male rat.
    Groom GV; Evans G
    Postgrad Med J; 1977; 53 Suppl 4():190-7. PubMed ID: 600896
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
    Gorriti MA; Rodríguez de Fonseca F; Navarro M; Palomo T
    Eur J Pharmacol; 1999 Jan; 365(2-3):133-42. PubMed ID: 9988095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.
    Tai S; Nikas SP; Shukla VG; Vemuri K; Makriyannis A; Järbe TU
    Psychopharmacology (Berl); 2015 Aug; 232(15):2751-61. PubMed ID: 25772338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the effect of clomipramine on the sleep of monkeys and man].
    Bert J; Saier J; Touré MF
    Rev Electroencephalogr Neurophysiol Clin; 1976; 6(1):23-5. PubMed ID: 184504
    [No Abstract]   [Full Text] [Related]  

  • 34. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of delta9-tetrahydrocannabinol with other pharmacological agents.
    Consroe P; Jones B; Laird H
    Ann N Y Acad Sci; 1976; 281():198-211. PubMed ID: 798523
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
    Dzoljic ED; Kaplan CD; Dzoljic MR
    Arch Int Pharmacodyn Ther; 1988; 294():64-70. PubMed ID: 3233054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of serotonin reuptake differentially affects heterosexual behavior of male and female rats.
    Hamburger-Bar R; Rigter H; Dekker I
    Life Sci; 1978 May; 22(20):1827-36. PubMed ID: 672432
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of clomipramine and other amine-uptake inhibitors on morphine analgesia in laboratory animals.
    Lee RL; Spencer PS
    Postgrad Med J; 1977; 53 Suppl 4():53-61. PubMed ID: 600899
    [No Abstract]   [Full Text] [Related]  

  • 39. Withdrawal from chronic treatment with metergoline, dl-propranolol and amitriptyline enhances serotonin receptor mediated behaviour in the rat.
    Stolz JF; Marsden CA
    Eur J Pharmacol; 1982 Apr; 79(1-2):17-22. PubMed ID: 7200899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of chronic lithium administration on stimulation-induced changes in forebrain 5-hydroxyindoles: modification by chlorimipramine [proceedings].
    Collard KJ
    Br J Pharmacol; 1976 Jul; 57(3):446P-447P. PubMed ID: 974341
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.